342 results on '"Patiño-García, Ana"'
Search Results
2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
3. Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma
4. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing
5. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
6. TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
7. Promises of oncolytic viral therapy for adult and children with brain glioma
8. Genetics of Obstructive Sleep Apnea
9. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
10. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
11. Genomic and proteomic profiling of osteosarcoma
12. Wnt signaling and Loxl2 promote aggressive osteosarcoma
13. Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report
14. Contributors
15. Designing clinical studies for biomarker discovery: The Design criteria
16. Somatic and germline analysis of a familial Rothmund–Thomson syndrome in two siblings with osteosarcoma
17. Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
18. Consequences of Delayed Diagnosis
19. Molecular Biology of Pediatric Bone Sarcomas
20. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells
21. Data from Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
22. Supplementary Figure from Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
23. Supplementary Data from Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
24. Table S3 from Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells
25. Data from Profiling of Chemonaive Osteosarcoma and Paired-Normal Cells Identifies EBF2 as a Mediator of Osteoprotegerin Inhibition to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis
26. Supp Figure 3 from Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
27. Figure S1 from Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells
28. Supplementary Data from Profiling of Chemonaive Osteosarcoma and Paired-Normal Cells Identifies EBF2 as a Mediator of Osteoprotegerin Inhibition to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis
29. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing
30. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
31. Lipid nanoparticles enhance the efficacy of chemotherapy in primary and metastatic human osteosarcoma cells
32. Immunotherapy with CAR-T cells in paediatric haematology-oncology
33. Inmunoterapia con células CAR-T en hematooncología pediátrica
34. Oncolytic Virotherapy for Gliomas
35. List of Contributors
36. The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
37. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
38. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models
39. Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk
40. Genetically Inferred Birthweight, Height, and Puberty Timing and Risk of Osteosarcoma
41. Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [18F]FDG and sodium [18F]fluoride PET
42. SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
43. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients
44. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma
45. Primary trimethylaminuria syndrome: more than an unpleasant odor
46. Molecular Biology of Pediatric Bone Sarcomas
47. Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer
48. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
49. Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
50. Abstract 2001: Delta-24-RGDOX oncolytic adenovirus improves the survival by modulating the immune system in DMG models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.